MIRALIMOGENE ENSOLISBAC
UNII I4UU4GZO8P

Substance Identification & Data

This profile provides standardized clinical and technical data for Miralimogene Ensolisbac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I4UU4GZO8P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
I4UU4GZO8P
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MIRALIMOGENE ENSOLISBAC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175824
National Cancer Institute reference terminology for clinical and research data.
INN ID
10368
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Miralimogene Ensolisbac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIRALIMOGENE ENSOLISBAC

Common Names & Synonyms

MIRALIMOGENE ENSOLISBAC [INN]

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus